Cargando…

Comment on ‘Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?’

Detalles Bibliográficos
Autores principales:	Liu, Yuying, Meng, Xianchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173706/ https://www.ncbi.nlm.nih.gov/pubmed/30206367 http://dx.doi.org/10.1038/s41416-018-0241-4

Ejemplares similares

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

Reply to ‘Comment on ‘Circulating Neutrophils in patients with hepatocellular carcinoma”
por: Chan, Stephen L., et al.
Publicado: (2018)

Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis
por: Li, Dan-Dan, et al.
Publicado: (2021)

Comment on: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
por: Liu, Kai, et al.
Publicado: (2022)

Tumor-associated neutrophils correlate with poor prognosis in diffuse large B-cell lymphoma patients
por: Manfroi, B., et al.
Publicado: (2018)

Comment on the risk of hepatocellular carcinoma with chronic hepatitis B infection in Sweden
por: Singh, Satender Pal, et al.
Publicado: (2022)

Comment on “State of the Art in Magnetic Resonance Imaging of Hepatocellular Carcinoma”: The Role of DWI
por: Granata, Vincenza, et al.
Publicado: (2019)

Reply to Comments on “State of the Art in Magnetic Resonance Imaging of Hepatocellular Carcinoma”: The Role of DWI
por: Horvat, Natally, et al.
Publicado: (2019)

Embryonic Morphogen Nodal Is Associated with Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Chen, Jing, et al.
Publicado: (2014)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
por: Cui, Yifeng, et al.
Publicado: (2019)

Elevated Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predicts Poor Outcome in Hepatocellular Carcinoma
por: von Felden, Johann, et al.
Publicado: (2020)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

Reply to: Comments on “Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma”
por: Li, Peng, et al.
Publicado: (2019)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Eschar is associated with poor prognosis in scrub typhus
por: Chauhan, Vivek, et al.
Publicado: (2017)

Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition
por: He, Lu, et al.
Publicado: (2014)

Association Between Olfactomedin 4 and Postoperative Prognosis in Patients With Early-Stage Hepatocellular Carcinoma
por: Chen, Wan-Yuan, et al.
Publicado: (2020)

Serotonin and YAP/VGLL4 Balance Correlated with Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Shu, Bo, et al.
Publicado: (2018)

Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Shi-Hong, et al.
Publicado: (2013)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Reply to ‘Comment on ‘MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma’’
por: Zhou, Shao-jun, et al.
Publicado: (2018)

CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma
por: Li, Li, et al.
Publicado: (2015)

RNA binding protein-based risk score model for prognosis prediction of patients with hepatocellular carcinoma
por: Xu, Shengjun, et al.
Publicado: (2022)

Comment on ‘MicroRNA-199b-5p attenuates TGF-β1-induced epithelial–mesenchymal transition in hepatocellular carcinoma’
por: Cristóbal, Ion, et al.
Publicado: (2018)

Author response to: Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma
por: Hobeika, Christian, et al.
Publicado: (2022)

Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
por: Sohn, Won, et al.
Publicado: (2023)

Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Qiuyue, et al.
Publicado: (2020)

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma
por: Guo, Xiaodong, et al.
Publicado: (2012)

Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma
por: Li, Chongyi, et al.
Publicado: (2015)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Comment to “Very late intubation in COVID-19 patients: A forgotten prognosis factor?”
por: Mellado-Artigas, Ricard, et al.
Publicado: (2022)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012)

Porphyria and hepatocellular carcinoma
por: Pierach, C.A.
Publicado: (1987)

DLC1 deficiency at diagnosis predicts poor prognosis in acute myeloid leukemia
por: Li, Xueqian, et al.
Publicado: (2022)

DNA methylation-mediated high expression of CCDC50 correlates with poor prognosis and hepatocellular carcinoma progression
por: Li, Chunhong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5l13sj0cmb0j8r7tfokr3j8t5j